2022 Capital Markets Day presentation

ROVI updates its strategy in a meeting with shareholders, investors and analysts


TO THE SPANISH NATIONAL SECURITIES MARKET COMMISSION

(COMISIÓN NACIONAL DEL MERCADO DE VALORES)

Madrid, 23 November 2022

In compliance with the reporting requirements provided for in article 227 of the consolidated text of the Securities Market Act, ROVI sends and publishes the attached presentation regarding the update of the company strategy, a presentation that will be distributed today and which can be accessed through the website of the company. Likewise, ROVI will hold an in-person and virtual meeting today with analysts and investors to present said presentation.

 

Mr. Juan López-Belmonte Encina

Chairman and Chief Executive Officer

Laboratorios Farmacéuticos ROVI, S.A.

 

Average: 3 (2 votes)
 
Related
ROVI forecasts that its 2024 operating revenue will be multiplied by between 1.5 and 1.8 in six years, driven primarily by an increase...
1 min
25/03/2025
​​Operating revenue in 2024 was 763.7 million euros, a 7.9% decrease on 2023, mainly due to the performance of the contract...
3 min
25/02/2025
Operating revenue in the first nine months of 2024 was 564.6 million euros, a 5% decrease on the first nine months of 2023, mainly due...
4 min
07/11/2024